Julia Somers

Julia Somers

Auto-generated profile, based on publicly available information

Julia Somers

Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97201, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Nano Today
Verified
Journal Article
Closed access
MUMehmet Altay Unal
Mehmet Altay Unal
FBFatma Bayrakdar
Fatma Bayrakdar
LFLaura Fusco
Laura Fusco
OBOmur Besbinar
Omur Besbinar
CSChristopher E. Shuck
Christopher E. Shuck
AYAçelya Yilmazer
Açelya Yilmazer

1 October 2021 in Molecular Systems Biology
Verified
Journal Article
Open access
MOMarek Ostaszewski
Marek Ostaszewski
Anna NiarakisAnna Niarakis
Anna Niarakis
AMAlexander Mazein
Alexander Mazein
IKInna Kuperstein
Inna Kuperstein
RPRobert Phair
Robert Phair
RSReinhard Schneider
Reinhard Schneider
We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS‐CoV‐2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large‐scale community effort to build an open access, interoperable and computable repository of COVID‐19 molecular mechanisms. The COVID‐19 Disease Map (C19DMap) is a graphical, interactive representation of disease‐relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph‐based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS‐CoV‐2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID‐19 or similar pandemics in the long‐term perspective.

15 February 2022 in Cell Reports Medicine
Verified
Journal Article
Open access
BJBrett E. Johnson
Brett E. Johnson
ACAllison L. Creason
Allison L. Creason
JSJayne Stommel
Jayne Stommel
JKJamie M. Keck
Jamie M. Keck
SPSwapnil Parmar
Swapnil Parmar
JGJoe W. Gray
Joe W. Gray
Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities.

1 December 2021 in Molecular Systems Biology
Verified
Journal Article
Open access
MOMarek Ostaszewski
Marek Ostaszewski
Anna NiarakisAnna Niarakis
Anna Niarakis
AMAlexander Mazein
Alexander Mazein
IKInna Kuperstein
Inna Kuperstein
RPRobert Phair
Robert Phair
RSReinhard Schneider
Reinhard Schneider
We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS‐CoV‐2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large‐scale community effort to build an open access, interoperable and computable repository of COVID‐19 molecular mechanisms. The COVID‐19 Disease Map (C19DMap) is a graphical, interactive representation of disease‐relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph‐based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS‐CoV‐2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID‐19 or similar pandemics in the long‐term perspective.

12 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FHFergus W. Hamilton
Fergus W. Hamilton
JSJulia Somers
Julia Somers
RMRuth E. Mitchell
Ruth E. Mitchell
PGPeter Ghazal
Peter Ghazal
NTNicholas J. Timpson
Nicholas J. Timpson
Introduction: Heme-oxygenase 1 (HMOX1) is a critical stress response gene that catalyzes the multistep oxidation of heme. A GT(n) repeat of variable length in the promoter in has been associated with a wide range of human diseases, including infections. This paper aims to summarise and systematically review associations between the length of the HMOX1 GT(n) promoter and infectious disease in humans.Methods: A search using relevant terms was performed in PubMED and EMBASE through to 15/01/21 identifying all research that studied an association between the HMOX1 GT(n) repeat polymorphism and the incidence and/or outcome of any human infectious disease. Citations were screened for additional studies. Potential studies were screened for inclusion by two authors. Data was extracted on allele frequency, genotype, strength of association, mechanism of genotyping, and potential biases. A narrative review was performed across each type of infection.Results: 1,533 studies were identified in the search, and one via citation screening. Sixteen studies were ultimately included, seven in malaria, three in HIV, three in sepsis, and one each in pneumonia, hepatitis C, and acute respiratory distress syndrome (ARDS). Sample sizes for nearly all studies were small (biggest study, n = 1,646). Allelic definition was different across all included studies. All studies were at some risk of bias. In malaria, three studies suggested that longer alleles were associated with reduced risk of severe malaria, particularly malaria-induced renal dysfunction, with four studies identifying a null association. In sepsis, two studies suggested an association with longer alleles and better outcomes.Conclusions: Despite the importance of HMOX1 in survival from infection, and the association between repeat length and gene expression, the clinical data supporting an association between repeat length and incidence and/or outcome of infection remain inconclusive.

28 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MOMarek Ostaszewski
Marek Ostaszewski
Anna NiarakisAnna Niarakis
Anna Niarakis
AMAlexander Mazein
Alexander Mazein
IKInna Kuperstein
Inna Kuperstein
RPRobert Phair
Robert Phair
RSReinhard Schneider
Reinhard Schneider
We describe a large-scale community effort to build an open-access, interoperable, and computable repository of COVID-19 molecular mechanisms - the COVID-19 Disease Map. We discuss the tools, platforms, and guidelines necessary for the distributed development of its contents by a multi-faceted community of biocurators, domain experts, bioinformaticians, and computational biologists. We highlight the role of relevant databases and text mining approaches in enrichment and validation of the curated mechanisms. We describe the contents of the Map and their relevance to the molecular pathophysiology of COVID-19 and the analytical and computational modelling approaches that can be applied for mechanistic data interpretation and predictions. We conclude by demonstrating concrete applications of our work through several use cases and highlight new testable hypotheses.